Baisi Medical

Guangzhou Baisi Medical Technology Co., Ltd. (hereinafter referred to as: Baisi Medical) was established in 2017, headquartered in Guangzhou, located on the 13th floor of Building B, National Science Park of Sun Yat-sen University, with branch (subsidiary) companies in Beijing, Zhuji, and Jiaxing. With the rapid development of the company, Baisi Medical has attracted outstanding talents from all over the world, including three national high-level talents, two IEEE Fellows/MICCAI Fellows, and one member of the European Academy of Sciences. The company's leadership team graduated from University of Science and Technology of China, Sun Yat-sen University, University of Michigan, Technical University of Munich, Johns Hopkins University, etc. The core management team comes from excellent enterprises in the medical industry, such as Philips, Siemens, Varian, Neusoft, etc. Employees with bachelor's degree or above account for over 80%, and those with master's degree or above account for over 40%.

Baisi Medical is committed to becoming a "leader in precise digital intelligent treatment", with products covering radiotherapy product line, surgical product line, and intelligent oncology solution platform. The company's products and services have been applied in over 800 oncology hospitals both domestically and internationally, providing treatment services to more than 1 million patients. All products are independently developed, and multiple technologies are at the international leading level. The company has obtained over 100 invention patents and entered substantive examination, and products have obtained 2 Class III and 3 Class II medical device certificates and US FDA registration. Baisi Medical's products and services have also expanded overseas, contributing to the health of all humanity.

With the mission of "freeing the world from the fear of cancer", Baisi Medical sincerely invites more outstanding talents to create and develop together!

2017.05 Established in Guangzhou
2017.07 Received tens of millions RMB in angel round financing (financing institution: China Growth Capital)
2017.10 Won the Hong Kong stop of 2017 G-Startup Global Innovation Competition
2018.06 Appeared at the National Nasopharyngeal Carcinoma Academic Conference and held a high-end closed-door seminar
2019.10 Award-winning enterprise in CSTRO AI contouring competition
2019.12 Listed on VB tumor radiotherapy informatization
2020.01 Reached strategic cooperation with Philips again
2021.12 Won the 2021 China Digital Medical Enterprise Top 100 Medical AI Enterprise award
2022.01 Received the "Digital Intelligent Assisted Diagnosis" award
2022.08 Received nearly 100 million RMB A+ round financing
2022.12 Honored as Guangzhou [Future Unicorn] and [High-precision and Advanced] enterprise
2023, Won China Medical AI Enterprise TOP 20, Future Medical 100,
2023, Recognized as provincial-level specialized, refined, distinctive, and innovative enterprise and provincial-level intellectual property demonstration enterprise
2023, MIT Technology Review China Digital Medical Top 50
2024.02 Received nearly 100 million RMB B round financing
....